Ask WhyRx anything, instantly
Our proprietary GPT interface empowers you to query in plain language and surface context-rich insights immediately. Whether probing adherence, reactions to new competitors, or emerging unmet needs, you’ll get clarity—fast.


Insights that evolve with your brand
This isn’t a one-time research snapshot. Add recurring questions or follow up with patients who sparked signals. Validate hypotheses, test ideas, and track behavior shifts over time—right from the platform.

WhyRx for Brand Managers
Validate messaging and patient journeys in minutes, not months.

WhyRx for Insights Leaders
Dispense defensible, timely data to break bottlenecks and secure internal buy-in.

WhyRx for Launch Teams
Build patient-centered launch plans powered by real-time narratives.

WhyRx for Executives
Invest confidently with insights that prove ROI.
The complete patient insights ecosystem
WhyRx is the spark, but not the full cycle. Within the Thrivable ecosystem, you can instantly explore deeper via targeted market research using the same patients and signals, and activate insights through seamless recruitment and engagement of patients who surfaced insights in WhyRx, or those who could support your clinical trial recruitment efforts.

Built to drive confident decisions
WhyRx insights are only as strong as the data behind them. That’s why our patient intelligence engine is built for trust, scale, and quality.
100k+ current and prospective drug and device users
Avoid the cost and delay of sourcing patients yourself, we’ve already built the community.
Hundreds of profile and experience data points
Gain a crystal-clear picture of each patient and display insights from the audiences that matter most.
Best-in-class fraud prevention
Each patient goes through stringent verification to ensure every insight is authentic and reliable.
Why Trust Thrivable
100k+
Patient patient panel, and growing
2,500+
Open-ended patient narratives
+80
Net promoter score

"Thrivable is an invaluable tool for any organization that wants to understand what matters most to their target market because of the quality of the patient panel and the reliability of the platform"
Senior Vice President for North America
